GB2140684A - Mineral oil composition for use in the treatment of eczema - Google Patents
Mineral oil composition for use in the treatment of eczema Download PDFInfo
- Publication number
- GB2140684A GB2140684A GB08311206A GB8311206A GB2140684A GB 2140684 A GB2140684 A GB 2140684A GB 08311206 A GB08311206 A GB 08311206A GB 8311206 A GB8311206 A GB 8311206A GB 2140684 A GB2140684 A GB 2140684A
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- paint
- eczema
- treatment
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
- A61K35/06—Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Paints Or Removers (AREA)
- Medicinal Preparation (AREA)
Abstract
A topical composition for the treatment of eczema comprises a mixture of a major part of mineral oil containing suspended carbon particles and a minor part of a paint containing a finely divided metallic pigment. The oil component with suspended carbon is preferably used engine oil from the sump of an internal combustion engine The metallic paint may be a silver, copper or gold coloured paint wherein the pigment is one or more of powdered zinc, copper, tin, antimony or preferably aluminium.
Description
SPECIFICATION
Composition for use in the treatment of eczema
This invention relates to a composition for use in the treatment of eczema.
Eczema is a name given to a variety of skin infections, the effect of which is to cause reddening and scaling of the skin giving rise to considerable discomfort through itching. Hitherto, the majority of treatments for eczema have not served so much to remove the source of infection but merely to suppress the itching effect so that the skin will be able to heal of its own accord.
Frequently such compositions are not effective and scratching of the skin continues to such an extent that healing never has much opportunity to take place.
It is an object of the present invention to provide a composition which when applied to an area of skin affected by eczema not only suppresses itching taking place but is efficacious in suppressing the eczema itself.
According to the present invention there is provided a composition for use in the treatment of eczema which is a mixture of a major part of mineral oil containing in suspension carbon particles and a minor part of a paint composition containing a metallic pigment therein.
The composition of this invention comprises two essential components both of which are readily available at relatively low cost. The mineral oil component containing suspended carbon may be simply spent engine oil from the sump of an internal combustion engine. Although such a composition is certainly dirty and totally unsuitable for internal consumption, when applied externally, no harmful effects have been observed.
There is therefore no need to employ fresh oil with suspended carbon therein and indeed, although it has not been possible to prove, it could well be that the inorganic and organic compounds found in spent engine oil are beneficial in the treatment of eczema.
The paint component of the composition of this invention is likewise harmless if applied to the skin. There are commonly employed in paints three types of metallic pigment to produce a socalled "metallic" paint. These are aluminium which is commonly employed in silver paint, bronze pigment containing the elements copper, tin, antimony and zinc which is commonly employed in gold paints and zinc pigment employed primarily in primer paints. The so-called silver paints containing aluminium pigment are preferably employed in the practice of this invention.
In producing the compositions of this invention, the paint is merely mixed with the spent engine oil. The ratio by volume between these components may be varied widely. In general the oil and paint will be employed in a ratio by volume offrom 10:1 to 30:1, preferably 1 5:1 to 25:1 and most preferably about 20:1. Thus a composition which has been found to the particularly effective has been produced by mixing 1 oz. (28.4 g) of commercially available silver paint with 1 pint (0.57 litre) of spent engine oil.
Treatment with the composition of this invention is effected by painting the composition on the affected area of skin by any convenient method. The skin is preferably left fully exposed to the air for as long as possible while the composition is in contact therewith. When the composition has dried, it may generally be removed by peeling. In usual cases, it will suffice for the composition to be applied daily for about one month. Generally treatment for more than two months will not be necessary.
The composition of this invention has been tested on about 200 subjects suffering from eczema. The treatment with the composition has been found to be successful in all cases.
1. A composition for use in the treatment of eczema which is a mixture of a major part of a mineral oil containing in suspension carbon particles and a minor part of a paint composition containing a metallic pigment therein.
2. A composition as claimed in claim 1, wherein the mineral oil containing in suspension carbon particles is spent engine oil from the sump of an internal combustion engine.
3. A composition as claimed in claim 1 or 2, wherein the paint composition is a silver paint containing aluminium pigment.
4. A composition as claimed in any one of the preceding claims, wherein the oil and paint are present in a ratio by volume of from 10:1 to 30:1.
5. A composition as claimed in claim 4, wherein the oil and paint are employed in a ratio by volume offrom 15:1 to 25:1.
6. A composition for use in the treatment of eczema, substantially as described herein.
**WARNING** end of DESC field may overlap start of CLMS **.
Claims (6)
1. A composition for use in the treatment of eczema which is a mixture of a major part of a mineral oil containing in suspension carbon particles and a minor part of a paint composition containing a metallic pigment therein.
2. A composition as claimed in claim 1, wherein the mineral oil containing in suspension carbon particles is spent engine oil from the sump of an internal combustion engine.
3. A composition as claimed in claim 1 or 2, wherein the paint composition is a silver paint containing aluminium pigment.
4. A composition as claimed in any one of the preceding claims, wherein the oil and paint are present in a ratio by volume of from 10:1 to 30:1.
5. A composition as claimed in claim 4, wherein the oil and paint are employed in a ratio by volume offrom 15:1 to 25:1.
6. A composition for use in the treatment of eczema, substantially as described herein.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB08311206A GB2140684B (en) | 1983-04-25 | 1983-04-25 | Mineral oil composition for use in the treatment of eczema |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB08311206A GB2140684B (en) | 1983-04-25 | 1983-04-25 | Mineral oil composition for use in the treatment of eczema |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8311206D0 GB8311206D0 (en) | 1983-06-02 |
| GB2140684A true GB2140684A (en) | 1984-12-05 |
| GB2140684B GB2140684B (en) | 1986-07-30 |
Family
ID=10541648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08311206A Expired GB2140684B (en) | 1983-04-25 | 1983-04-25 | Mineral oil composition for use in the treatment of eczema |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2140684B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6719987B2 (en) | 2000-04-17 | 2004-04-13 | Nucryst Pharmaceuticals Corp. | Antimicrobial bioabsorbable materials |
| US6989156B2 (en) | 2001-04-23 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Therapeutic treatments using the direct application of antimicrobial metal compositions |
| US7201925B2 (en) | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
| WO2008151640A3 (en) * | 2007-06-09 | 2009-02-05 | Mustapha Lefkir | Product for combating the reappearance of hair |
| US8865227B2 (en) | 2007-12-20 | 2014-10-21 | Smith & Nephew (Overseas) Limited | Metal carbonate particles and methods of making thereof |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
| AU2001278322B2 (en) | 2000-07-27 | 2005-12-22 | Smith & Nephew (Overseas) Limited | Treatment of hyperproliferative skin disorders and diseases |
| US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
| US7255881B2 (en) | 2000-07-27 | 2007-08-14 | Nucryst Pharmaceuticals Corp. | Metal-containing materials |
| US20030185901A1 (en) | 2000-07-27 | 2003-10-02 | Burrell Robert E. | Methods of treating conditions with a metal-containing material |
| US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| US6989157B2 (en) | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
| US20030180379A1 (en) | 2000-07-27 | 2003-09-25 | Burrell Robert E. | Solutions and aerosols of metal-containing compounds |
| US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
-
1983
- 1983-04-25 GB GB08311206A patent/GB2140684B/en not_active Expired
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6719987B2 (en) | 2000-04-17 | 2004-04-13 | Nucryst Pharmaceuticals Corp. | Antimicrobial bioabsorbable materials |
| US6989156B2 (en) | 2001-04-23 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Therapeutic treatments using the direct application of antimicrobial metal compositions |
| US7201925B2 (en) | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
| WO2008151640A3 (en) * | 2007-06-09 | 2009-02-05 | Mustapha Lefkir | Product for combating the reappearance of hair |
| US8865227B2 (en) | 2007-12-20 | 2014-10-21 | Smith & Nephew (Overseas) Limited | Metal carbonate particles and methods of making thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| GB8311206D0 (en) | 1983-06-02 |
| GB2140684B (en) | 1986-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2140684A (en) | Mineral oil composition for use in the treatment of eczema | |
| CA2208078A1 (en) | Formulations and methods for reducing skin irritation | |
| CA2151884A1 (en) | Diecasting alloy | |
| AU697817B2 (en) | Sorbent compositions for sulfur removal | |
| CA2108192A1 (en) | Use of tyloxapol as a nanoparticle stabilizer and dispersant | |
| ZA837976B (en) | Imidazolylalkylthienyl-tetrahydropyridazines and processes for their preparation | |
| AU560726B2 (en) | Triazolo(3,4-a)phthalazine and their use as anti-anxiety agents | |
| BR8206165A (en) | 1,2-ALCANODIOL BORATED COMPOUND, LUBRICATING OIL COMPOSITION AND PROCESS TO REDUCE THE OIL CONSUMPTION OF AN INTERNAL COMBUSTION ENGINE | |
| ATE170979T1 (en) | PREPARATION AND STABILIZATION OF CELL SUSPENSIONS | |
| GR3031321T3 (en) | Isothiourea derivatives as no synthase inhibitors | |
| ES2051760T3 (en) | NEW CERIO IV COMPOUND AND ITS PREPARATION PROCEDURE. | |
| KR880002608A (en) | Submerged Ike Welding Flux | |
| IL105489A0 (en) | Compositions and methods for improving the wetting of particulates | |
| ATE185071T1 (en) | STEROID-CONTAINING EYE COMPOSITIONS AND THEIR USE IN THE TREATMENT OF GLAUCOMA | |
| CA2010606A1 (en) | Lubricating oil compositions and additives for use therein | |
| IE792418L (en) | Diazines. | |
| AU1543283A (en) | Biostimulating agent containing creatine | |
| ES8501397A1 (en) | Amino derivatives of benzylidene-pyrrolo[2,1-b]quinazolines useful for treating conditions of allergic origin | |
| RU96111994A (en) | COMPOSITION FOR PROTECTION AGAINST CORROSION AND THERMAL-OXIDATIVE TURNING OF CONNECTED SURFACES | |
| JPS57207651A (en) | Treatment of inorganic pigment | |
| EP0264530A2 (en) | Solvent for paint | |
| RU96124223A (en) | COOLING LIQUID FOR INTERNAL COMBUSTION ENGINES | |
| GB959509A (en) | Improvements relating to nickel-chromium alloys | |
| SU852910A1 (en) | Composition "klemma-2" for ultrasound treatment of metals | |
| RU93003065A (en) | CHARGE FOR BEAST-FREE DECOMPOSITION OF METAL-CONTAINING MATERIALS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19950425 |